GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GPT Healthcare Ltd (NSE:GPTHEALTH) » Definitions » Research & Development

GPT Healthcare (NSE:GPTHEALTH) Research & Development : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is GPT Healthcare Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. GPT Healthcare's Research & Development for the three months ended in Mar. 2024 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.

GPT Healthcare Research & Development Historical Data

The historical data trend for GPT Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GPT Healthcare Research & Development Chart

GPT Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Research & Development
- - - -

GPT Healthcare Quarterly Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Research & Development Get a 7-Day Free Trial - - - - -

GPT Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GPT Healthcare  (NSE:GPTHEALTH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

GPT Healthcare Research & Development Related Terms

Thank you for viewing the detailed overview of GPT Healthcare's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

GPT Healthcare (NSE:GPTHEALTH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GPT Healthcare Ltd (NSE:GPTHEALTH) » Definitions » Research & Development
Comparable Companies
Traded in Other Exchanges
544131:India
Address
GPT Centre, JC-25, Sector III, Salt Lake, Kolkata, WB, IND, 700106
Website
https://ilshospitals.com
GPT Healthcare Ltd is engaged in healthcare sector. It operates a chain of mid-sized full service hospitals under the ILS brand and provide integrated healthcare services, with a focus on secondary and tertiary care and operates four multispecialty hospitals in Dum Dum, Salt Lake and Howrah in West Bengal and Agartala in Tripura with a total capacity of 561 beds. It offers a comprehensive range of healthcare services across over 35 specialties and super specialties, including internal medicine and diabetology, nephrology (including renal transplants), laparoscopic and general surgery, gynaecology and obstetrics, critical care, gastroenterology, orthopaedics and joint replacements, interventional cardiology, neurology, neurosurgery, paediatrics, and neonatology.

GPT Healthcare (NSE:GPTHEALTH) Headlines

No Headlines